EPS Bio Technology Corp. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was TWD 480.28 million compared to TWD 477.6 million a year ago.

Revenue was TWD 480.28 million compared to TWD 477.6 million a year ago. Net income was TWD 18.64 million compared to TWD 31.7 million a year ago. Basic earnings per share from continuing operations was TWD 0.78 compared to TWD 1.33 a year ago.

Diluted earnings per share from continuing operations was TWD 0.78 compared to TWD 1.33 a year ago.